HGV 8.89% 4.9¢ hygrovest limited

News: MMJ Phytotech to update on Cannabidiol pill

  1. MMJ Phytotech (ASX:MMJ) is preparing to provide an update on its CBD (Cannabidiol) pill, with the ASX granting the company a trading halt to prepare.

    The company recently raised $4.8 million and has previously said that it is expecting revenues from CBD pill sales.

    Earlier in the month MMJ's subsidiary, PhytoTech Therapeutics, received official National approval in Israel to commence a Phase I Clinical Study to assess the safety and performance of its proprietary oral capsule formulations.

    PhytoTech Therapeutics intends to commence the study by November 2015, with initial results expected as early as Q1 2016.

    The halt will remain in place until the opening of trade on Monday 31st August 2015, or earlier if an announcement is made to the market.

     

 
watchlist Created with Sketch. Add HGV (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.004(8.89%)
Mkt cap ! $10.30M
Open High Low Value Volume
4.6¢ 4.9¢ 4.6¢ $2.898K 61.25K

Buyers (Bids)

No. Vol. Price($)
1 45528 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 32750 1
View Market Depth
Last trade - 15.09pm 03/05/2024 (20 minute delay) ?
Last
4.7¢
  Change
0.004 ( 4.08 %)
Open High Low Volume
4.7¢ 4.7¢ 4.7¢ 25000
Last updated 12.47pm 03/05/2024 ?
HGV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.